Cynata Therapeutics Ltd (CYP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.969x

Based on the latest financial reports, Cynata Therapeutics Ltd (CYP) has a cash flow conversion efficiency ratio of -0.969x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.79 Million ≈ $-4.10 Million USD) by net assets (AU$5.98 Million ≈ $4.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Cynata Therapeutics Ltd worth for the company's overall valuation and market capitalisation.

Cynata Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Cynata Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cynata Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cynata Therapeutics Ltd ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Cynata Therapeutics Ltd to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Gabather AB (publ) ST:GABA	-0.117x
Eagle Eye Solutions Group plc LSE:EYE	0.125x
ALLIANCE ONE INT F:DM8	-0.057x
EVERYBODY LOVES LANGUAGES F:VB6	N/A
PowerCompute, Inc. NASDAQ:PWCM	-0.253x
Midwich Group PLC LSE:MIDW	0.268x
Induct AS OL:INDCT	N/A
Sino Hua-An International Bhd KLSE:2739	-0.019x

Annual Cash Flow Conversion Efficiency for Cynata Therapeutics Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Cynata Therapeutics Ltd from 2008 to 2025. View CYP live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$5.98 Million ≈ $4.23 Million	AU$-8.72 Million ≈ $-6.17 Million	-1.458x	-5.63%
2024-06-30	AU$7.22 Million ≈ $5.11 Million	AU$-9.96 Million ≈ $-7.05 Million	-1.380x	-61.69%
2023-06-30	AU$16.73 Million ≈ $11.84 Million	AU$-14.28 Million ≈ $-10.11 Million	-0.854x	-520.04%
2022-06-30	AU$23.96 Million ≈ $16.95 Million	AU$-3.30 Million ≈ $-2.33 Million	-0.138x	+24.35%
2021-06-30	AU$28.37 Million ≈ $20.08 Million	AU$-5.16 Million ≈ $-3.65 Million	-0.182x	+9.81%
2020-06-30	AU$16.79 Million ≈ $11.88 Million	AU$-3.39 Million ≈ $-2.40 Million	-0.202x	+67.25%
2019-06-30	AU$10.97 Million ≈ $7.76 Million	AU$-6.76 Million ≈ $-4.78 Million	-0.616x	-133.37%
2018-06-30	AU$15.39 Million ≈ $10.89 Million	AU$-4.06 Million ≈ $-2.87 Million	-0.264x	+9.59%
2017-06-30	AU$13.86 Million ≈ $9.81 Million	AU$-4.05 Million ≈ $-2.86 Million	-0.292x	+42.44%
2016-06-30	AU$8.58 Million ≈ $6.07 Million	AU$-4.35 Million ≈ $-3.08 Million	-0.507x	-70.56%
2015-06-30	AU$8.75 Million ≈ $6.19 Million	AU$-2.60 Million ≈ $-1.84 Million	-0.297x	-58.11%
2014-06-30	AU$9.85 Million ≈ $6.97 Million	AU$-1.85 Million ≈ $-1.31 Million	-0.188x	+59.64%
2013-06-30	AU$1.64 Million ≈ $1.16 Million	AU$-765.76K ≈ $-541.83K	-0.466x	+45.44%
2012-06-30	AU$853.75K ≈ $604.08K	AU$-729.33K ≈ $-516.05K	-0.854x	+68.73%
2011-06-30	AU$971.93K ≈ $687.70K	AU$-2.66 Million ≈ $-1.88 Million	-2.732x	-30.36%
2010-06-30	AU$932.00K ≈ $659.45K	AU$-1.95 Million ≈ $-1.38 Million	-2.096x	-65.58%
2009-06-30	AU$961.98K ≈ $680.66K	AU$-1.22 Million ≈ $-861.47K	-1.266x	-94.87%
2008-06-30	AU$2.21 Million ≈ $1.56 Million	AU$-1.44 Million ≈ $-1.02 Million	-0.649x	--

About Cynata Therapeutics Ltd

AU:CYP Australia Biotechnology

Market Cap

$1.85 Million

AU$2.61 Million AUD

Market Cap Rank

#30188 Global

#1762 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.40

All Time High

AU$1.84